Tag Archives: Regulus Therapeutics

Bio-Techne Corporation and Regulus Therapeutics announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease (ADPKD) treatment. Regulus has...

Read More »